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Role of Cytoskeletal 
Dynamics in Platelet 
Arf6 Activation
Abstract 
Platelets	 undergo	morphological	 changes	 upon	

















event	 in	 platelet	 activation.	 We	 then	 assessed	
the	 role	 of	 microtubule	 disassembly	 and	 actin	
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Introduction
Platelets	are	 responsible	 for	maintaining	 the	 integrity	
of	 the	vascular	 system.	They	 seal	 off	 vascular	 injury	
by	adhering	to	lesions,	aggregating,	and	secreting	their	








































Results and Discussion 































Figure 1. Effect of vinblastine on platelet aggrega-
tion and dense core granule release. 
A,B) Washed platelets were pre-incubated with the indi-
cated concentration of vinblastine or equivalent volume 
of DMSO (vehicle) for 5 minutes prior to stimulation. 
Platelets were stimulated with (A) thrombin (0.3 U/mL) 
or (B) convulxin (0.1 µg/mL) and monitored for shape 
change and aggregation over 5 minutes. 
C) Washed platelets were pre-incubated with 25 
µL luciferin-luciferase (Chrono-Lume) and 2.5 µM vin-
blastine or equivalent volume of DMSO (vehicle) for 
5 minutes prior to stimulation. Thrombin (0.3 U/mL) 
was used to stimulate the platelet solution to monitor 
dense core granule ATP release. 
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Role of microtubule remodeling in Arf6 
activation
Because	we	observed	an	important	role	for	microtubule	







nocodazole,	 or	 paclitaxel-treated	 platelets	 following	
stimulation	with	thrombin	or	convulxin.	















in	 PAR-mediated	 platelet	 activation.	 Because	Arf6	 is	





likely	 because	Arf6	 activation	would	be	disrupted	 in	
both	PAR	and	GPVI-mediated	activation.	
Figure 2. Effect of nocodazole on platelet aggrega-
tion and dense core granule release. 
A,B) Washed platelets were pre-incubated with the indi-
cated concentration of nocodazole or equivalent volume 
of DMSO (vehicle) for 5 minutes prior to stimulation. 
Platelets were stimulated with (A) thrombin (0.3 U/mL) 
or (B) convulxin (0.1 µg/mL) and monitored for shape 
change and aggregation over 5 minutes. 
C) Washed platelets were pre-incubated with 25 
µL luciferin-luciferase (Chrono-Lume) and 5 µM no-
codazole or equivalent volume of DMSO (vehicle) for 5 
minutes prior to stimulation. Thrombin (0.3 U/mL) was 
used to stimulate the platelet solution to monitor dense 
core granule ATP release. 
Figure 3. Effect of paclitaxel on platelet aggregation 
and dense core granule release. 
A,B) Washed platelets were pre-incubated with the indi-
cated concentration of paclitaxel or equivalent volume 
of DMSO (vehicle) for 5 minutes prior to stimulation. 
Platelets were stimulated with (A) thrombin (0.3 U/mL) 
or (B) convulxin (0.1 µg/mL) and monitored for shape 
change and aggregation over 5 minutes. 
C) Washed platelets were pre-incubated with 25 
µL luciferin-luciferase (Chrono-Lume) and 1.25 µM 
paclitaxel or equivalent volume of DMSO (vehicle) for 
5 minutes prior to stimulation. Thrombin (0.3 U/mL) 
was used to stimulate the platelet solution to monitor 
dense core granule ATP release. 
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Role of actin assembly in platelet 
activation and aggregation
Actin	filaments	make	up	 the	majority	 of	 the	platelet	
cytoskeleton	and	are	 responsible	 for	 the	morphologi-
cal	changes	seen	in	platelet	activation	(Hartwig,	2006;	
Lefebvre	 et	 al.,	 1993;	Natarajan	 et	 al.,	 2000;	Torti	 et	
al.,	1996;	White,	1984;	Winokur	and	Hartwig,	1995).	
Aggregometry	was	used	to	re-examine	the	role	of	actin	








Figure 4. Effect of microtubule inhibitors on Arf6-
GTP levels. 
A, B) Washed platelets were pre-incubated with the 
indicated concentration of vinblastine, nocodazole, or 
paclitaxel for 5 minutes prior to stimulation. Platelets 
were stimulated with (A) thrombin (0.3 U/mL) or (B) 
convulxin (0.1 µg/mL) and allowed to aggregate for 5 
minutes. Platelets were lysed at the end of the aggrega-
tion reaction and the clarified supernatants were assayed 
for Arf6-GTP, using GST-GGA3. Arf6-GTP was identified 
using SDS-PAGE/Western blot analysis. The data points 
are normalized to the amount of Arf6-GTP in resting 
platelets (100%). 
Figure 5. Time course of Arf6-GTP in platelets pre-
incubated with paclitaxel. 
A, B) Washed platelets were pre-treated with 2.5 
µM paclitaxel for 5 minutes prior to stimulation. Plate-
lets were stimulated with (A) thrombin (0.3 U/ml) or 
(B) convulxin (0.1 µg/mL) and allowed to aggregate 
for the indicated times (10, 30, 60, 120, or 300 sec). 
Platelets were lysed at the indicated time points and 
the clarified supernatants were analyzed for Arf6-GTP, 
using GST-GGA3, and Arf6-Total. Arf6 was identified 
using SDS-PAGE/Western blot analysis. Data points are 
represented as a ratio of Arf6-GTP to Arf6-Total and are 
normalized to the Arf6-GTP/Arf6-Total ratio in resting 
platelets (100%). 
B r e t t  t a y l o r  B e g l e yr o l e  o f  c y t o s k e l e t a l  d y n a m i c s  i n  P l a t e l e t  a r f 6  a c t i V a t i o n
T h E  U n I v E r S I T y  O f  K E n T U C K y  J O U r n A L  O f  U n D E r g r A D U AT E  S C h O L A r S h I P   
Role of actin as-









































We	 then	determined	 a	 role	 for	 these	 cytoskeletal	
remodeling	 events	 in	Arf6	 activation.	Both	paclitaxel	
and	 latrunculin	 A	 treatment	 disrupted	 Arf6	 activity,	
suggesting	 that	 microtubule	 disassembly	 and	 actin	






cytoskeletal	 remodeling	 events	 to	 Arf6	 signaling	 in	
platelets.	
Figure 6. Effect of latrunculin A on platelet shape change and aggregation. 
Washed platelets were pre-incubated with the indicated concentration of latrunculin A or 
equivalent volume of DMSO (vehicle) for 5 minutes prior to stimulation. Platelets were 
stimulated with convulxin (0.1 µg/mL) and monitored for shape change and aggregation 
over 5 minutes. 
Figure 7. 
Effect of latrunculin A on Arf6-GTP levels. 
Washed platelets were pre-incubated with the indicated 
concentration of latrunculin A or equivalent volume 
of DMSO (vehicle) for 5 minutes prior to stimulation. 
Platelets were stimulated with convulxin (0.1 µg/mL) 
and monitored for shape change and aggregation for 
the indicated times [(A) 300 sec] or [(B) 10, 30, 60, 120, 
300, or 600 sec]. Following lysis at the indicated time 
points, clarified supernatants were assayed for Arf6-GTP, 
using GST-GGA3, and Arf6-Total. Arf6 was identified 
using SDS-PAGE/Western blot analysis. Data points are 
represented as a ratio of Arf6-GTP to Arf6-Total and are 
normalized to the Arf6-GTP/Arf6-Total ratio in resting 
platelets (100%). 
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